To conclude, we investigated the biological context of the SFRP4 biomarker by using comprehensive spatial and multiomics analysis of heterogenous prostate cancer tissue, an approach not previously applied to analyze SFRP4. Here, SFRP4 is linked to prostate carcinoma.